About | Free Trial

Last Update

2016-05-09T00:00:00.000Z

This profile was last updated on // .

Is this you? Claim your profile.

Background Information

Education

M.S.
Pharmacy
University of Iceland

Web References (22 Total References)


Teva to Present at the Bank of America Merrill Lynch 2016 Health Care Conference | Business Wire

feeds.businesswire.com [cached]

Siggi Olafsson will present on Tuesday, May 10, 2016 at 8:40 AM PT.

...
Siggi Olafsson, President and CEO, Global Generic Medicines,
Teva Pharmaceutical Industries Ltd.


Teva to Present at the Bank of America Merrill Lynch 2016 Health Care Conference | Business Wire

feeds.businesswire.com [cached]

Siggi Olafsson will present on Tuesday, May 10, 2016 at 8:40 AM PT.

...
Siggi Olafsson, President and CEO, Global Generic Medicines,
Teva Pharmaceutical Industries Ltd.


Teva to Present at the Bank of America Merrill Lynch 2016 Health Care Conference | Business Wire

feeds.businesswire.com [cached]

Siggi Olafsson will present on Tuesday, May 10, 2016 at 8:40 AM PT.

...
Siggi Olafsson, President and CEO, Global Generic Medicines,
Teva Pharmaceutical Industries Ltd.


Actavis plc Names Board of Directors :: Durata Therapeutics, Inc. (DRTX)

www.duratatherapeutics.com [cached]

Siggi O. Olafsson joins the Actavis plc Board of Directors effective following the closing of the Warner Chilcott acquisition. Mr. Olafsson is the President of Actavis Pharma Actavis' generic, branded generic, legacy brands and over-the-counter business. He joined the Company as Executive Vice President, Global Generics in September 2010, and was appointed President of the Global Generics business in April 2012. Prior to joining the Company, Mr. Olafsson served as CEO of the Actavis Group (the legacy Actavis business acquired by the Company in 2012), where he was responsible for overseeing the Company's global pharmaceutical business with operations in more than 40 countries. Prior to joining the Actavis Group, Mr. Olafsson held increasingly responsible positions with Pfizer's Global Research and Development organization in both the U.S. and the UK from 1998 until 2003, and served as head of Drug Development for Omega Farma in Iceland for four years. Mr. Olafsson has a M.S. in Pharmacy (Cand Pharm) from the University of Iceland.


We are pleased to launch generic ...

www.tmcnet.com [cached]

We are pleased to launch generic Aripiprazole tablets and offer a generic treatment for patients suffering from schizophrenia and bipolar I disorder," said Siggi Olafsson, President and CEO, Global Generic Medicines for Teva.

Similar Profiles

Other People with this Name

Other people with the name Olafsson

Olaf Olafsson
AOL Time Warner Inc

Bjørn Olafsson
TTS Kocks GmbH Korea Co

Sverrir Olafsson

Olaf Olafsson
Investing.com

Kristofer Olafsson
Radwell Communication

Browse ZoomInfo's Business Contact Directory by City

Browse ZoomInfo's
Business People Directory

Browse ZoomInfo's
Advanced Company Directory